← Evidence map

ReviewNeurology2026

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Yael Hacohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42647788